Hyperterm interperitoneal kemoterapi ved den primære operation for gastrointestinal cancer

Thea Helene Degett, Hans-Christian Pommergaard, Ismail Gögenur

Abstract

Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis. HIPEC administered at the primary operation in high-risk patients may also be effective in preventing peritoneal carcinomatosis and improve survival in patients with advanced gastrointestinal cancer.

Bidragets oversatte titelHyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind179
Udgave nummer12
Sider (fra-til)V06160454
ISSN0041-5782
StatusUdgivet - 20 mar. 2017

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hyperterm interperitoneal kemoterapi ved den primære operation for gastrointestinal cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater